NURO News and Press, NeuroMetrix Inc. From 07/20/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Neurobo Pharmaceuticals (NASDAQ: NRBO ) stock is on the rise Tuesday as retail traders take a liking to the biotechnology company. Source: Bukhta Yurii / Shutterstock.com The recent interest from retail trader...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Robinhood is holding a roadshow this weekend to go over details of the company’s upcoming initial public offering (IPO). Source: mundissima / Shutterstock.com The Robinhood IPO Roadshow is set to take place...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips NeuroMetrix (NASDAQ: NURO ) stock is surging higher on Tuesday after getting “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA). Source: Shutterstock The breakthro...

Gainers: NeuroBo Pharmaceuticals (NRBO) +50%, NeuroMetrix (NURO) +41%, Immunome (IMNM) +31%, Endo International (ENDP) +21%, PLx Pharma (PLXP) +18%.Losers: Ardelyx (ARDX) -75%, Allied Healthcare Products (AHPI) -22%, NRx Pharmaceuticals (...

WOBURN, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell ® device has received Breakthrough Designation from the U.S. Food and Drug Administration (FDA) for treating the symptoms of fibromyalgia in adults. Fibromyalgia i...

WOBURN, Mass., July 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 second quarter financial results before the opening of the market on July 22, 2021. The Company will host a conference call at 8:00 a.m., Eastern Time on July 22...

WOBURN, Mass., June 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology will be used in a double-blinded, randomized, sham-controlled trial to determine whether transcutaneous electrical nerve stimulation (TENS) is an effective, acceptable and...

Clearside Biomedical (CLSD) +52% after positive results from early-stage wet AMD trial.Torchlight Energy Resources (TRCH) +33% after declaring special preferred dividend.Unique Fabricating (UFAB) +29%.Ocugen (OCGN) +20% after securing manufacturing partnership for COVAXIN in th...

NeuroMetrix (NURO) perks up 6.6% premarket after announcing top-line results from Quell trial in patients with fibromyalgia. Quell is a novel transcutaneous electrical nerve stimulator ((TENS)) that is indicated for relief and management of chronic pain. A poster titled "Outcom...

WOBURN, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that top-line results from a randomized controlled trial of Quell in patients with fibromyalgia will be presented at two upcoming pain medicine conferences. The double-blind, randomized, s...